About Yili Chuanning Biotechnology Company

The company is a subsidiary of Sichuan Colun Pharmaceutical Co., Ltd. invested and established in the Yining Industrial Park in the Khorgos Economic Development Zone in Xinjiang in December 2010. The Khorgos Economic Development Zone is the core area of the Silk Road Economic Belt of the country's “Belt and Road” development strategy, and is mainly engaged in the development and industrialization of biological fermentation technology. It is mainly engaged in the development and industrialization of biofermentation technology and synthetic biological products. The main products include erythromycin thiocyanate, cephalosporin intermediates (7-ACA, 7-ADCA, D-7ACA), penicillin intermediates (6-APA, penicillin G potassium salt), crude ursodeoxycholic acid, coenzyme Q10 mycelium, etc. Corporate honors: In 2019, the Xinjiang Uygur Autonomous Region Department of Industry and Information Technology approved the “Tianchi Doctor Program” project; approved as the “Xinjiang Uyghur Autonomous Region High-tech Enterprise” in 2020; the “National Environmental Protection Antibiotic Bacterial Residue Harmless Treatment and Resource Utilization Engineering Technology Center” established by the company passed the inspection; in 2021, it was approved by the Autonomous Region Human Resources and Social Security Department to establish the Autonomous Region Postdoctoral Research Workstation, etc. It won the honorary title of “National Model Worker”.